RVL Pharmaceuticals plc Gross Profit
RVL Pharmaceuticals plc reported Gross Profit of $6.31 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement
us-gaap:GrossProfit · last filed 2023-08-14
- RVL Pharmaceuticals plc gross profit for the quarter ending 2023-06-30 was $6.31M, a 1.46% increase year-over-year.
- RVL Pharmaceuticals plc gross profit for the quarter ending 2023-03-31 was $6.53M, a 66.15% decline year-over-year.
- RVL Pharmaceuticals plc gross profit for the quarter ending 2022-12-31 was $7.25M, a 307.82% increase year-over-year.
- RVL Pharmaceuticals plc gross profit for the quarter ending 2022-09-30 was $7.50M, a 614.68% increase year-over-year.
- RVL Pharmaceuticals plc gross profit for fiscal 2022 was $40.27M, a 190.03% increase from fiscal 2021.
- RVL Pharmaceuticals plc gross profit for fiscal 2021 was $13.88M, a 43.26% decline from fiscal 2020.
- RVL Pharmaceuticals plc gross profit for fiscal 2020 was $24.47M.
- RVL Pharmaceuticals plc gross profit for fiscal 2018 was $123.62M.
| Period end | Gross Profit 3 month | Gross Profit 3 month as first filed | Gross Profit 6 month | Gross Profit 6 month as first filed | Gross Profit 9 month | Gross Profit 9 month as first filed | Gross Profit 12 month | Gross Profit 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $6.31M 10-Q · filed 2023-08-14 | $12.85M 10-Q · filed 2023-08-14 | $20.09M derived: sum of 3 quarters · filed 2023-08-14 | $27.59M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2023-03-31 | $6.53M 10-Q · filed 2023-05-11 | $13.78M derived: sum of 2 quarters · filed 2023-05-11 | $21.28M derived: sum of 3 quarters · filed 2023-05-11 | $27.50M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-12-31 | $7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $14.74M derived: sum of 2 quarters · filed 2023-03-20 | $20.96M derived: sum of 3 quarters · filed 2023-08-14 | $40.27M 10-K · filed 2023-03-20 | ||||
| 2022-09-30 | $7.50M 10-Q · filed 2022-11-10 | $13.72M derived: sum of 2 quarters · filed 2023-08-14 | $33.02M 10-Q · filed 2022-11-10 | $34.80M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-06-30 | $6.22M 10-Q · filed 2023-08-14 | $25.52M 10-Q · filed 2023-08-14 | $27.30M derived: sum of 3 quarters · filed 2023-08-14 | $28.35M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $19.30M 10-Q · filed 2023-05-11 | $21.08M derived: sum of 2 quarters · filed 2023-05-11 | $22.13M derived: sum of 3 quarters · filed 2023-05-11 | $32.93M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $2.83M derived: sum of 2 quarters · filed 2023-03-20 | $13.63M derived: sum of 3 quarters · filed 2023-03-20 | $13.88M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | $1.05M 10-Q · filed 2022-11-10 | $11.85M derived: sum of 2 quarters · filed 2022-11-10 | $12.11M 10-Q · filed 2022-11-10 | $11.74M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $10.80M 10-Q · filed 2022-08-11 | $11.06M 10-Q · filed 2022-08-11 | $10.69M derived: sum of 3 quarters · filed 2022-08-11 | $35.26M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $256.00K 10-Q · filed 2022-05-12 | $10.39M 10-Q · filed 2021-05-13 | -$108.00K derived: sum of 2 quarters · filed 2022-05-12 | $24.46M derived: sum of 3 quarters · filed 2022-05-12 | $24.43M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | -$364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $24.20M derived: sum of 2 quarters · filed 2022-03-30 | $24.18M derived: sum of 3 quarters · filed 2022-03-30 | $24.47M 10-K · filed 2022-03-30 | $103.40M 10-K · filed 2021-03-30 | |||
| 2020-09-30 | $24.57M 10-Q · filed 2021-11-15 | $40.45M 10-Q · filed 2020-11-10 | $24.54M derived: sum of 2 quarters · filed 2021-11-15 | $24.83M 10-Q · filed 2021-11-15 | $86.05M 10-Q · filed 2020-11-10 | -$40.28M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | -$27.00K 10-Q · filed 2021-08-16 | $17.54M 10-Q · filed 2020-08-11 | -$31.00K 10-Q · filed 2021-08-16 | $45.60M 10-Q · filed 2020-08-11 | -$64.85M derived: sum of 3 quarters · filed 2021-09-08 | -$26.70M derived: sum of 4 quarters · filed 2021-09-08 | ||
| 2020-03-31 | $28.06M 10-Q · filed 2021-05-13 | -$64.82M derived: sum of 2 quarters · filed 2021-09-08 | -$26.67M derived: sum of 3 quarters · filed 2021-09-08 | -$1.78M derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2019-12-31 | -$92.88M derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | -$54.73M derived: sum of 2 quarters · filed 2021-09-08 | -$29.84M derived: sum of 3 quarters · filed 2021-09-08 | -$1.92M 8-K · filed 2021-09-08 | $128.40M 10-K · filed 2020-03-19 | |||
| 2019-09-30 | $38.15M 10-Q · filed 2020-11-10 | $38.15M 10-Q · filed 2019-11-14 | $63.04M derived: sum of 2 quarters · filed 2020-11-10 | $90.96M 10-Q · filed 2020-11-10 | $90.96M 10-Q · filed 2019-11-14 | $119.07M derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | $24.89M 10-Q · filed 2020-08-11 | $24.89M 10-Q · filed 2019-08-08 | $52.81M 10-Q · filed 2020-08-11 | $52.81M 10-Q · filed 2019-08-08 | $80.92M derived: sum of 3 quarters · filed 2020-08-11 | $113.91M derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | $27.92M 10-Q · filed 2020-05-12 | $27.92M 10-Q · filed 2019-05-09 | $56.03M derived: sum of 2 quarters · filed 2020-05-12 | $89.02M derived: sum of 3 quarters · filed 2020-05-12 | $126.31M derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | $28.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $61.10M derived: sum of 2 quarters · filed 2020-03-19 | $98.38M derived: sum of 3 quarters · filed 2020-03-19 | $123.62M 10-K · filed 2020-03-19 | $128.69M 10-K · filed 2019-03-28 | |||
| 2018-09-30 | $32.99M 10-Q · filed 2019-11-14 | $34.33M 10-Q · filed 2018-11-08 | $70.27M derived: sum of 2 quarters · filed 2019-11-14 | $95.51M 10-Q · filed 2019-11-14 | $98.85M 10-Q · filed 2018-11-08 | $121.57M derived: sum of 4 quarters · filed 2019-12-20 | ||
| 2018-06-30 | $37.29M 10-Q · filed 2019-11-14 | $38.18M 10-Q · filed 2019-08-08 | $62.52M 10-Q · filed 2019-11-14 | $64.32M 10-Q · filed 2019-08-08 | $88.58M derived: sum of 3 quarters · filed 2019-12-20 | $120.86M derived: sum of 4 quarters · filed 2019-12-20 | ||
| 2018-03-31 | $25.23M 10-Q · filed 2019-11-14 | $26.24M 10-Q · filed 2019-05-09 | $51.29M derived: sum of 2 quarters · filed 2019-12-20 | $83.57M derived: sum of 3 quarters · filed 2019-12-20 | ||||
| 2017-12-31 | $26.06M derived: 8-K 12 month − 10-Q 9 month · filed 2019-12-20 | $58.34M derived: sum of 2 quarters · filed 2019-12-20 | $118.11M 8-K · filed 2019-12-20 | $120.56M 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | $32.28M 10-Q · filed 2018-11-08 | $92.05M 10-Q · filed 2018-11-08 |